Registry study for the surveillance of patients participating in prospective phase I,II or III studies including Ventricular Assist Tissue (VAT)

Recruiting

• Conditions: I50; Heart failure

• Registration Number: DRKS00027292
• Lead Sponsor: niversitätsmedizin Göttingen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-01-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 53

Inclusion Criteria

Participation in VAT-trial

Exclusion Criteria

not applicable

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Observation period until end of life:<br>- Frequency of major adverse cardiac events (MACE; non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death) <br>- Hospitalization for worsening of heart failure <br>- NYHA class <br>- Ejection fraction (assessed by echocardiography or MRI) <br>- Frequency and severity of arrhythmic events <br>- Change of NTproBNP <br>- Time to mechanical circulatory assist device or heart transplantation <br>- All-cause mortality

Secondary Outcome Measures

Name	Time	Method
not applicable